Helen Trifonopoulos
Vice President, Health Policy and Patient Access, Oncology, Novartis
Helen Trifonopoulos is the Vice-President of Health Policy and Patient Access at Novartis Oncology. She leads a team of professionals responsible for health economics and outcomes research, value and access strategy, government and stakeholder relations, and health systems partnerships.
Helen has over 20 years of experience in the pharmaceutical industry working for Merck and Novartis. She has held roles in commercial, medical education, policy and reimbursement across multiple therapeutic areas and various phases of the product life cycle. Most recently, Helen has had the privilege of working in novel areas like immuno-oncology and cell and gene therapies
Helen’s professional interests lie in exploring ways members of the healthcare ecosystem can work towards enhancing the life sciences in Canada and enabling patient access to innovative therapies while partnering for health system sustainability.
Helen holds a Bachelor of Arts in Political Science from McGill University and an MBA from the John Molson School of Business.
Helen Trifonopoulos is the Vice-President of Health Policy and Patient Access at Novartis Oncology. She leads a team of professionals responsible for health economics and outcomes research, value and access strategy, government and stakeholder relations, and health systems partnerships.
Helen has over 20 years of experience in the pharmaceutical industry working for Merck and Novartis. She has held roles in commercial, medical education, policy and reimbursement across multiple therapeutic areas and various phases of the product life cycle. Most recently, Helen has had the privilege of working in novel areas like immuno-oncology and cell and gene therapies
Helen’s professional interests lie in exploring ways members of the healthcare ecosystem can work towards enhancing the life sciences in Canada and enabling patient access to innovative therapies while partnering for health system sustainability.
Helen holds a Bachelor of Arts in Political Science from McGill University and an MBA from the John Molson School of Business.
